Bioceres Crop Solutions (BIOX) Liabilities and Shareholders Equity (2017 - 2026)

Bioceres Crop Solutions has reported Liabilities and Shareholders Equity for 10 years, with the latest figure at $531.4 million in Q1 2026.

• Quarterly Liabilities and Shareholders Equity fell 33.43% year-over-year to $531.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.6 billion (down 21.82% YoY) and the FY2025 annual result came in at $763.6 million, down 10.43% from the prior year.
• Liabilities and Shareholders Equity eased to $531.4 million in Q1 2026 per BIOX's latest filing, from $560.4 million in the prior quarter.
• Over five years, Liabilities and Shareholders Equity peaked at $872.9 million in Q4 2022 and troughed at $503.6 million in Q1 2022.
• A 5-year average of $748.4 million and a median of $818.1 million in 2023 frame the typical range for Liabilities and Shareholders Equity.
• The sharpest annual moves came in 2022 and 2026: Liabilities and Shareholders Equity soared 902.63% in 2022, then tumbled 33.43% in 2026.
• Over 5 years, Liabilities and Shareholders Equity stood at $872.9 million in 2022, then dropped by 6.11% to $819.5 million in 2023, then gained by 1.91% to $835.2 million in 2024, then sank by 32.91% to $560.4 million in 2025, then fell by 5.17% to $531.4 million in 2026.
• According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $531.4 million, $560.4 million, and $734.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.